Literature DB >> 487313

Measurement of ataxia and related neurological signs in the laboratory rat.

F B Jolicoeur, D B Rondeau, E Hamel, R F Butterworth, A Barbeau.   

Abstract

The purpose of the present study was to design a standard battery of tests capable of quantitatively characterizing ataxia and concomitant neurological signs in the rat. In addition to a systematic analysis of the walking gait of animals, tests for activity, catalepsy, rigidity, and various reflexive responses were included in the battery. The standardization and validation of the test system was performed by determining and comparing profiles of neurobehavioral effects produced by 3-acetyl pyridine, acrylamide, pyrithiamine, and thiamine deficiency, four experimental treatments reported to induce ataxia in animals. Results indicate that profiles of neurobehavioral disturbances accompanying ataxia in animals varied distinctively with each experimental treatment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487313     DOI: 10.1017/s0317167100119663

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  11 in total

1.  Pyrithiamine-induced thiamine deficiency results in decreased Ca(2+)-dependent release of glutamate from rat hippocampal slices.

Authors:  O Lê; M Héroux; R F Butterworth
Journal:  Metab Brain Dis       Date:  1991-09       Impact factor: 3.584

2.  Glucose loading precipitates acute encephalopathy in thiamin-deficient rats.

Authors:  C Zimitat; P F Nixon
Journal:  Metab Brain Dis       Date:  1999-03       Impact factor: 3.584

Review 3.  Animal behavioral methods in neurotoxicity assessment: SGOMSEC joint report.

Authors:  B Kulig; E Alleva; G Bignami; J Cohn; D Cory-Slechta; V Landa; J O'Donoghue; D Peakall
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

4.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex.

Authors:  R F Butterworth; J F Giguere; A M Besnard
Journal:  Neurochem Res       Date:  1985-10       Impact factor: 3.996

5.  Oxidative metabolism and acetylcholine synthesis during acetylpyridine treatment.

Authors:  G E Gibson; J P Blass
Journal:  Neurochem Res       Date:  1985-04       Impact factor: 3.996

6.  Activities of thiamine-dependent enzymes in two experimental models of thiamine deficiency encephalopathy: 3. Transketolase.

Authors:  J F Giguère; R F Butterworth
Journal:  Neurochem Res       Date:  1987-03       Impact factor: 3.996

7.  Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy.

Authors:  J F Giguère; R F Butterworth
Journal:  Neurochem Res       Date:  1984-09       Impact factor: 3.996

8.  Regional alterations of thiamine phosphate esters and of thiamine diphosphate-dependent enzymes in relation to function in experimental Wernicke's encephalopathy.

Authors:  M Héroux; R F Butterworth
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

9.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. alpha-Ketoglutarate dehydrogenase.

Authors:  R F Butterworth; J F Giguère; A M Besnard
Journal:  Neurochem Res       Date:  1986-04       Impact factor: 3.996

10.  Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages.

Authors:  Simon R W Stott; Emmanouil Metzakopian; Wei Lin; Klaus H Kaestner; Rene Hen; Siew-Lan Ang
Journal:  J Neurosci       Date:  2013-05-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.